Clinical Trials
10 trialsNCT04915183 2026-06-05
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07407582 2026-06-05
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
Phase 1/2 Recruiting
NCT01451853 2026-06-03
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Sound Pharmaceuticals, Incorporated
Phase 2 Withdrawn
NCT07622407 2026-06-03
TIMELY REHAB
VA Office of Research and Development
Phase NA Not yet recruiting
NCT06781749 2026-05-11
New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss
University of Southern California
Recruiting
NCT07420751 2026-04-28
Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis
Massachusetts General Hospital
Phase NA Active not recruiting
NCT07218913 2026-04-17
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
Phase 1 Recruiting
NCT06036407 2026-04-14
HEAR
University of Bern
Phase NA Completed
NCT06517888 2026-04-06
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
Phase 1/2 Recruiting
NCT07503613 2026-04-06
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
Akouos, Inc.
Enrolling by invitation